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Christopher M. Sassettia
aDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School,
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ABSTRACT Two efﬁcient recombination systems were combined to produce a ver-
satile method for chromosomal engineering that obviates the need to prepare
double-stranded DNA (dsDNA) recombination substrates. A synthetic “targeting oli-
gonucleotide” is incorporated into the chromosome via homologous recombina-
tion mediated by the phage Che9c RecT annealase. This oligonucleotide contains
a site-speciﬁc recombination site for the directional Bxb1 integrase (Int), which
allows the simultaneous integration of a “payload plasmid” that contains a cog-
nate recombination site and a selectable marker. The targeting oligonucleotide
and payload plasmid are cotransformed into a RecT- and Int-expressing strain,
and drug-resistant homologous recombinants are selected in a single step. A li-
brary of reusable target-independent payload plasmids is available to generate
gene knockouts, promoter replacements, or C-terminal tags. This new system is
called ORBIT (for “oligonucleotide-mediated recombineering followed by Bxb1 inte-
grase targeting”) and is ideally suited for the creation of libraries consisting of large
numbers of deletions, insertions, or fusions in a bacterial chromosome. We demon-
strate the utility of this “drag and drop” strategy by the construction of insertions or
deletions in over 100 genes in Mycobacterium tuberculosis and M. smegmatis.
IMPORTANCE We sought to develop a system that could increase the usefulness of
oligonucleotide-mediated recombineering of bacterial chromosomes by expanding
the types of modiﬁcations generated by an oligonucleotide (i.e., insertions and dele-
tions) and by making recombinant formation a selectable event. This paper de-
scribes such a system for use in M. smegmatis and M. tuberculosis. By incorporating a
single-stranded DNA (ssDNA) version of the phage Bxb1 attP site into the oligonu-
cleotide and coelectroporating it with a nonreplicative plasmid that carries an attB
site and a drug selection marker, we show both formation of a chromosomal attP
site and integration of the plasmid in a single transformation. No target-speciﬁc ds-
DNA substrates are required. This system will allow investigators studying mycobac-
terial diseases, including tuberculosis, to easily generate multiple mutants for analy-
sis of virulence factors, identiﬁcation of new drug targets, and development of new
vaccines.
KEYWORDS Mycobacterium smegmatis, bacteriophage genetics, gene replacement,
genetic fusions, metabolic engineering, promoter replacements, recombineering,
tuberculosis
Following the use of the laborious plasmid cointegration schemes that dominatedthe early days of gene replacement in bacteria, recent advances in genetic engi-
neering of bacteria have largely relied on phage recombination systems, including both
site-speciﬁc and homologous systems. For example, it was recognized in 1993 that a
nonreplicating plasmid containing the mycobacterial phage L5 attP site could be
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incorporated into the Mycobacterium smegmatis chromosome via integration into the
bacterial attB site (1); a similar system was described a year later for Escherichia coli (2).
Such events are dependent on the expression of phage integrases (Int). Thus, genes
expressed from endogenous or regulatable promoters could be delivered into the
stable conﬁnes of the chromosome in single-copy form, without the physiological
artifacts of excessive gene copy numbers or the instability of self-autonomous replica-
tion vectors. Site-speciﬁc recombination (SSR) systems were the basis for development
of the Lambda InCh method for transferring exogenous genes to the E. coli attB site (3);
development of the series of conditional-replication, integration, and modular (CRIM)
plasmids that take advantage of a variety of different phage attB sites in E. coli (4);
development of mycobacterial phage vectors for delivery of exogenous sequences to
mycobacterial chromosomes (5–7); and for many technical modiﬁcations of these SSR
systems and their substrates for use in metabolic and genetic engineering protocols in
a variety of organisms (8–12).
In addition to these site-speciﬁc recombination systems, general homologous re-
combination (HR) systems of phage, such as the Red system of phage lambda, and the
RecET systems of Rac prophage and mycobacterial phage Che9c, have been widely
used for genetic engineering in a variety of bacteria (13–19; for reviews, see reference
20, 21, and 22). Termed “recombineering,” these procedures have used both double-
stranded DNA (dsDNA) and single-stranded DNA oligonucleotides for generating bac-
terial chromosomal modiﬁcations in E. coli and in various bacterial pathogens, including
enterohemorrhagic E. coli (23), Salmonella enterica (20, 24–26), Shigella ﬂexneri (27),
Pseudomonas aeruginosa (28, 29), Yersinia pestis (30, 31), andM. tuberculosis (18, 19). The
Che9c RecT system has been especially useful for the veriﬁcation of drug-resistant
single nucleotide polymorphisms (SNPs) in the search for new drug targets for tuber-
culosis (32, 33). These general phage recombination systems have also been used for
the development of new methodologies for metabolic engineering of industrial micro-
organisms (34–43). In particular, the Red system annealase,  Beta protein, has been
employed in many protocols for the systematic modiﬁcation of E. coli. For example,
oligonucleotides have been electroporated into cells expressing  Beta to target the
promoter regions of genes, allowing accelerated evolution of E. coli for speciﬁc meta-
bolic engineering purposes (44). In concert with these homologous recombination
systems, the SSR systems described above have been employed to remove selectable
drug cassettes for the construction of markerless gene deletions and fusions (14, 16,
45).
The new system described in this report couples the recombinogenic annealing of
an oligonucleotide and the site-speciﬁc insertion of a nonreplicating plasmid into a
one-step procedure for generating chromosomally tagged genes, deletions, or pro-
moter replacements in M. smegmatis or M. tuberculosis. It takes advantage of a
voluminous amount of work done in the laboratory of G. Hatfull on both the Bxb1
phage integration system (5, 46–52) and the Che9 RecET recombineering system (17,
19), without which the development of this methodology would not be possible. It is
the ﬁrst general chromosomal engineering technique that produces a drug-selectable
recombinant that does not require the use of either target-speciﬁc dsDNA plasmids or
PCR-generated recombination substrates. The only target-speciﬁc substrate require-
ment for gene modiﬁcation is a chemically synthesized oligonucleotide. This “targeting
oligo” carries the ssDNA version of the Bxb1 phage attP site (48 bases) ﬂanked by 45 to
70 bases of homology to the chromosomal target and is coelectroporated with a
nonreplicating “payload plasmid” that contains a Bxb1 attB site. The host (M. smegmatis
or M. tuberculosis) contains a plasmid that expresses both the Che9c phage RecT
annealase and the Bxb1 phage integrase. RecT promotes annealing of the targeting
oligonucleotide to the lagging strand template of the replication fork, thus placing the
attP site into a precise location in the chromosome dictated by the oligonucleotide
sequence. In the same outgrowth period, Bxb1 integrase promotes site-speciﬁc recom-
bination between the coelectroporated attB-containing payload plasmid and the
oligonucleotide-derived attP site. In this system, the sequence of the oligonucleotide
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deﬁnes the position of the insertion site and the plasmid delivers the payload. For
knockouts, the oligonucleotide is designed such that attP replaces the target gene. For
C-terminal tags, the oligonucleotide is designed to insert attP at the end of the coding
sequence. In this case, the type of C-terminal tag desired is deﬁned by the selection of
the plasmid to be coelectroporated with the oligonucleotide from a library of preex-
isting payload plasmids. Inherently in this system, a single oligonucleotide designed to
create a C-terminal tag can be used with multiple plasmids to create ﬂuorescent,
degradation, and epitope-tagged fusions. This new gene modiﬁcation scheme is called
ORBIT (for “oligonucleotide-mediated recombineering followed by Bxb1 integrase tar-
geting”). We describe the use of the system to generate over 100 gene knockouts and
fusions in M. smegmatis and M. tuberculosis at high efﬁciency. This system could easily
be employed in other bacteria as well, provided that an ssDNA annealing protein (most
likely from an endogenous phage system) is available for use (see Discussion).
RESULTS
RecT-promoted oligonucleotide-mediated recombineering—60-bp insertion.
Two different types of recombineering methodologies have been applied to mycobac-
teria, but neither represents a broadly generalizable approach for genome engineering.
Target-speciﬁc dsDNA substrates can be used to make diverse and selectable muta-
tions. However, while PCRs with long oligonucleotides can extend homologous regions
to lengths of 100 to 150 bp, the most efﬁcient recombinant frequencies are obtained
with a selectable marker containing 500 bp of ﬂanking homology. When many genes
are being interrogated, these dsDNA constructs can be cumbersome to generate for
each desired mutation. In contrast, single-stranded oligonucleotides are easily synthe-
sized and can be used to alter one or a few bases of the chromosome at high efﬁciency.
However, these mutations are generally not selectable and are therefore difﬁcult to
isolate. An ideal method would leverage easily synthesized and highly efﬁcient oligo-
nucleotide substrates to make selectable mutations. We sought to accomplish this by
encoding a phage attachment site (attP) in the oligonucleotide that could be used to
integrate a selectable marker at a speciﬁc chromosomal site via site-speciﬁc recombi-
nation.
To test the feasibility of this idea, an assay was designed to measure the frequency
of incorporation of an oligonucleotide containing an insertion of approximately the size
of a 48-bp attP site into the mycobacterial chromosome. For this purpose, a hygromycin
resistance (Hygr) gene, with an internal 60-bp deletion, was integrated into the L5
phage attachment site of the M. smegmatis chromosome. Oligonucleotides (180-mers)
targeting the lagging strand template of the impaired Hygr marker and containing the
missing 60 bases (as well as 60 bases ﬂanking the deletion site) were electroporated
into M. smegmatis expressing the Che9c RecT annealase from the anhydrotetracycline
(ATc)-inducible Ptet promoter (pKM402) (32). The frequency of oligonucleotide incor-
poration was determined as the number of Hygr transformants among the survivors of
electroporation (Fig. 1a). The number of Hygr transformants generated ranged from
fewer than 10 to over 300, depending on the amount of oligonucleotide used (Fig. 1b).
At about 1 g of oligonucleotide, the total number of Hygr recombinants plateaued at
approximately 350 transformants/ml, which corresponds to a frequency of 2 106
recombinants per survivor of electroporation. In an experiment where the target
contained a 1-bp change creating a premature stop codon in the hyg resistance gene,
a 60-base oligonucleotide was used to restore Hyg resistance at a frequency of
4 104 recombinants per survivor of electroporation. Thus, the RecT annealase is
capable of integrating an oligonucleotide that contains a 60-base insertion into the
mycobacterial chromosome, albeit at a frequency which is 500-fold lower than that
seen with a single base pair change.
Development of ORBIT. To convert the recombineering of an oligonucleotide into
a selectable event, we determined if coelectroporation of the attP-containing oligonu-
cleotide with an attB-containing nonreplicating vector (Hygr) into a cell that expresses
both the RecT annealase and the phage Bxb1 integrase would allow both homologous
Oligo Recombineering and Bxb1 Integrase Targeting ®
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and site-speciﬁc recombination events to occur within the same outgrowth period.
Since the oligonucleotide is designed to direct the integration of the genetic informa-
tion contained in the nonreplicating plasmid, these elements were termed “targeting
oligonucleotide” and “payload plasmid.”
Two plasmids were generated to test this methodology. pKM444 produces the
recombination functions. This mycobacterial shuttle vector expresses both the Che9c
phage RecT annealase and the Bxb1 phage integrase (Int) from an anhydrotetracycline
(ATc)-inducible Ptet promoter (Fig. 2a). pKM446 is a payload plasmid that does not
replicate in mycobacteria. This vector includes a hyg resistance marker for selection in
mycobacteria and a Bxb1 attB site (Fig. 2b). Adjacent to the attB site is a sequence
encoding both a Flag tag and a DAS4 peptide tag designed to be in frame with a
targeted chromosomal gene following integration of the plasmid. The DAS4 tag
directs a fusion protein for degradation via the ClpXP system upon expression of the
SspB adapter protein (53, 54). Targeting oligonucleotides were designed to direct the
integration of attP to the 3= ends of the M. smegmatis recA, divIVA, and leuB genes,
immediately before the stop codon. A site-speciﬁc recombination event between the
inserted attP and the coelectroporated pKM446 would generate a DAS4 fusion to
these target genes (see Table S1 in the supplemental material for the list of oligonu-
cleotides used in this study). Targeting oligonucleotides, which anneal to the lagging
strand template of the replication fork, were coelectroporated with the pKM446
payload plasmid into M. smegmatis expressing both Che9c RecT annealase and Bxb1
integrase. Among the Hygr colonies resulting from these transformations, 9 of 12
candidates tested by PCR contained the expected recombinant structure, in which
pKM446 was inserted between attR and attL sites at the predicted oligonucleotide-
directed integration site (Fig. 2c to e). The fusion of the target genes to the Flag-DAS4
degradation tag was veriﬁed by sequencing the PCR products of the 5= junctions. The
design of the ORBIT oligonucleotide used to create the recA–Flag-DAS4 fusion is
described in Fig. S1 in the supplemental material; the relevant sequence of the
FIG 1 RecT-promoted oligonucleotide-mediated 60-base insertion. (a) Diagram of oligonucleotide-
mediated recombineering of a chromosomal target in M. smegmatis. An integrating plasmid (pKM433) at
the L5 phage attachment site contains a mutated hyg resistance gene due to an internal 60-bp deletion
(red square). Electroporation of an oligonucleotide containing the 60 bases missing in the target gene,
along with 60 bp of ﬂanking DNA on each side, was electroporated into cells expressing the Che9c RecT
function from pKM402. (b) After induction of RecT and preparation of the cells for transformation (as
described in Materials and Methods), the cells were electroporated with various amounts of an oligo-
nucleotide (180 mer) that spans the 60-bp deletion of the Hyg resistance cassette in pKM433. Cells were
grown overnight in 7H9 broth, and half the culture volume was plated on LB-Hyg plates. The experiment
was performed in triplicate; standard errors are shown.
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pKM446-integrating plasmid is shown in Fig. S2, and the sequence of a generic
chromosomal Flag-DAS4 fusion in shown in Fig. S3.
To test the functionality of the tag and to verify that the mutated locus represented
the only copy of the targeted gene in the cell, we took advantage of the DAS4
sequence, which promotes degradation of the tagged proteins upon induction of SspB
in M. smegmatis and M. tuberculosis (55–57). Two different sspB expression systems
were used, both of which induce degradation of the target protein either by adding ATc
(Tet-OFF) or by removing ATc (Tet-ON).
Cells containing the recA-DAS4 fusion were transformed with pGMCgS-TetON-18,
allowing the induction of SspB in the absence of ATc; RecA function was then
quantiﬁed using a UV resistance assay. Grown in the presence of ATc, the recA-DAS4-
tagged strain containing the SspB-expressing plasmid and a strain containing a control
FIG 2 Plasmids constructed for ORBIT. (a) Construct pKM444 expresses the Che9c phage RecT annealase and the Bxb1 phage integrase, both driven from the
Ptet promoter. A similar construct (pKM461) additionally contains the sacRB counter-selectable marker for curing the plasmid following gene modiﬁcation. (b)
One of the ORBIT payload plasmids (pKM446) used for integration into the chromosomal attP site created by an oligonucleotide. In this case, the plasmid
payload contains a Flag-DAS4 inducible degradation tag that is ultimately going to be fused to the 3= end of the target gene. Camr, chloramphenicol
resistance. (c) Three genes in M. smegmatis were targeted for C-terminal tagging. Following the ORBIT protocol for each target gene, the total numbers of
colonies obtained (from multiple trials) ranged between 20 to 200 CFU/transformation. Electroporations performed with payload plasmid only (no targeting
oligonucleotides) produced, on average, 5-fold-lower total numbers of colonies. The number of correct recombinants (of 4 candidates tested) for each target
gene is shown. (d) PCR analysis of the 5= junctions of each candidate tested. (e) Primer positions for veriﬁcation by PCR of the recombinants are shown. Blue
arrows, 5= junction; brown arrows, 3= junction. In each case where a 5= junction was veriﬁed, the 3= junction was also veriﬁed (not shown). The 5= junctions were
conﬁrmed by DNA sequencing.
Oligo Recombineering and Bxb1 Integrase Targeting ®
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plasmid showed nearly identical levels of UV sensitivity (Fig. 3a, right). In contrast, the
sensitivity of the tagged strain with SspB was enhanced in the absence of ATc (Fig. 3a,
left). The divIVA and leuB DAS4-tagged strains were transformed with pGMCgS-
TetOFF-18, which produces SspB upon ATc addition. In both cases, addition of ATc
inhibited the growth of these mutants, consistent with the essentiality of these genes
on the media used in this study (Fig. 3b and c). The defect of LeuB depletion could be
reversed by the addition of leucine to the plates, verifying that that this phenotype was
linked to the engineered mutation (data not shown). Thus, the ORBIT method could
generate function-altering mutations without the need to construct either target-
speciﬁc plasmids or long dsDNA recombineering substrates.
The scheme of using RecT and Bxb1 integrase simultaneously to promote modiﬁ-
cation of a chromosomal target gene is diagrammed in Fig. 4; the process is called
ORBIT (for “oligonucleotide-mediated recombineering followed by Bxb1 integrase tar-
geting”). In theory, targeting oligonucleotides could also be designed to delete a
portion of the chromosome during the ORBIT reaction (Fig. 4, right side) to create
knockouts. Demonstrations of such ORBIT-promoted knockouts are described below.
Parameters of ORBIT-promoted gene targeting. Two features of ORBIT that were
optimized were the length of the homologous arms (HAs) in the targeting oligonucle-
otide and the relative amounts of oligonucleotide and nonreplicating plasmid used for
coelectroporation. The HAs of a polA-targeting oligonucleotide were adjusted to
lengths of 50 to 70 bases (oligonucleotide lengths, including attP, were 148 to 188
bases in length). In each case, the attP sequence was placed between the last codon of
polA and its stop codon (similarly to the recA oligonucleotide used as described above;
see Fig. S1). The oligonucleotides were mixed with 200 ng of payload plasmid pKM446
and transformed into M. smegmatis containing pKM444 induced with ATc; a
gentamicin-resistant integrating plasmid was included as a transformation control.
While there was variability with respect to the number of Hyg-resistant transformants
FIG 3 Knockdown phenotypes of ORBIT-generated DAS4-tagged strains. The growth phenotypes of
the Flag-DAS4 tagged strains constructed as described in the Fig. 2 legend were analyzed after
transformation of an SspB-expressing plasmid. (a) The recA–Flag-DAS4 strain was transformed with an
SspB-producing plasmid, pGMCgS-TetON-18 (streptomycin resistance [Strepr]), under the control of the
reverse TetR repressor. In this scenario, RecA is degraded in the absence of anhydrotetracycline (ATc).
Ten-fold serial dilutions of the cells grown overnight without ATc were spotted on LB-streptomycin
plates, either with or without ATc, and the cells were exposed to 20 J/m2 of UV. Preferential UV sensitivity
of the recA–Flag-DAS4 strain in the absence of ATc was determined by comparing the levels of growth
seen with and without the inducer. (b) The divIVA–Flag-DAS4 strain was transformed with an SspB-
producing plasmid, pGMCgS-TetOFF-18 (Strepr), under the control of the wild-type TetR repressor. In this
case, DivIVA is expected to be depleted in the presence of ATc. Preferential growth of the DivIVA–Flag-
DAS4 strain on LB plates in the presence of ATc was determined by comparing the levels of growth
seen with and without the inducer. (c) The experiment was performed as described for panel B, except
that leuB was the target and the cells were plated on 7H10-AD plates.
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from each electroporation, oligonucleotides containing longer HAs produced more
transformants (Fig. 5a). For HAs with sequences below 40 bp in length, no Hygr
transformants were observed above the number seen in the no-oligonucleotide control
(data not shown).
We also examined the optimal ratio of oligonucleotide to plasmid. Targeting oligo-
nucleotide (1 g) was coelectroporated with various amounts of the pKM446 payload
plasmid. More Hygr transformants were observed when more plasmid was used, but
there was also a small increase in the number of oligonucleotide-independent trans-
formants that presumably represent illegitimate recombinants (Fig. 5b). PCR screening
conﬁrmed that 39/40 Hygr transformants recovered in this experiment (using 8 candi-
dates of each transformation) represented the desired oligonucleotide-directed recom-
bination events. As a rule, we generally combined 1 g of oligonucleotide with 200 ng
of plasmid in the transformations described below.
ORBIT-promoted knockdowns and knockouts in M. smegmatis and M. tubercu-
losis. To determine if ORBIT-promoted modiﬁcations could be generally engineered
throughout the chromosome, we targeted a variety of genes in M. tuberculosis and M.
smegmatis. For C-terminal tags, the attP site was placed between the last translating
codon of the target gene and its stop codon (see Fig. S1 for how attP is placed within
the M. smegmatis recA gene to create a C-terminal fusion). The ORBIT system is
FIG 4 ORBIT-promoted gene alteration. The ORBIT process is initiated at the replication fork. An oligomer containing a single-stranded
version of the Bxb1 attP site (top pictures, red lines) is coelectroporated with an attB-containing nonreplicating plasmid into a
mycobacterial host cell expressing both RecT annealase and Bxb1 integrase. RecT promotes annealing of the oligonucleotide to the
lagging strand template. Following DNA replication through this region, an attP site is formed in the chromosome (middle pictures). In
the same outgrowth period, Bxb1 integrase promotes site-speciﬁc insertion of the plasmid into the chromosome (attB  attP). (Left side)
The oligonucleotide is designed such that attP is inserted just before the stop codon. The integration event fuses the GFP tag in frame
to the 3= end of the target gene (with an attL site in frame between them); the recombinant is selected for by Hygr. (Right side) The
oligonucleotide is designed such that attP replaces the target gene and the plasmid integration event allows hygromycin resistance to
be used to select for the knockout.
Oligo Recombineering and Bxb1 Integrase Targeting ®
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designed such that all oligonucleotides used for any type of C-terminal fusion are
constructed in a similar manner (i.e., with the attP site placed as indicated in Fig. S1).
This is important, as all ORBIT-integrating plasmids that are designed to generate
C-terminal fusions have a 2-bp sequence (CG) placed between the attB site and the
relevant tag (see Fig. S2). These 2 bp, together with the 43 bp of the attL site created
after integration, ensure that all target genes are translationally fused to the tag
supplied by the integrating vector (see Fig. S3 for details). For knockouts, the attP site
was ﬂanked by 60 to 70 bases, which typically included the ﬁrst and last 10 codons of
the target gene (including the start and termination codons), which is expected to
result in the deletion of intervening chromosomal sequence. Overall, we have made
over 100 strains where the target genes were either deleted or C-terminally tagged (see
Fig. 6 and Tables 1 and 2). For most of these targets, between 5 to 50 colonies typically
arose after plating 25% of the overnight outgrowth (0.5 ml), though in some cases,
plates contained over 100 colonies. Usually, only 2 to 4 Hygr candidates were analyzed
by PCR to identify at least one strain that contained the payload plasmid integrated into
the site designated by the targeting oligonucleotide. Most of the targeting oligonu-
cleotides used for these genomic modiﬁcations contained either 60 or 70 bases of
ﬂanking homology. An oligonucleotide targeting the aceE gene containing only 45
bases of homology on each side of attP also produced the desired recombinant in 4 of
6 clones. However, lowering ﬂanking homologies to below 40 bases decreased the
percentage of correct recombinants dramatically, largely as a result of an increased
number of illegitimate recombination events.
In order to cure recombinants of the RecT-Int-producing plasmid following modiﬁ-
cation, pKM461, a sacB-containing derivative of pKM444, was constructed. A number of
FIG 5 Parameters of the ORBIT process. (A) The amount of target homology ﬂanking the attP site in an
oligonucleotide designed to create a polA–Flag-DAS4 fusion in M. smegmatis was examined as a
function of recombinant formation (Hygr). One microgram of each oligonucleotide was electroporated
with 200 ng of pKM446. The frequency of targeting is expressed as the percentage of Hygr transformants
following integration of pKM446 relative to a transformation control (20 ng of gentamicin resistance
[Genr] plasmid pKM390). Experiments were performed in triplicate; standard errors are shown. Gent,
gentamicin. (B) Colony counts were determined after electroporation of 1 g of an oligonucleotide with
70-base ﬂanks (designed to create a polA–Flag-DAS4 fusion) with various amounts of pKM446. CFU
counts per milliliter were determined following overnight growth of the electroporation mixtures in 2 ml
LB. Experiments were performed in triplicate; standard errors are shown.
Murphy et al. ®
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FIG 6 ORBIT-generated insertions and deletions in M. tuberculosis and M. smegmatis. Gene deletions and
modiﬁcations were performed at a variety of positions in the chromosomes of both M. tuberculosis (a) and M.
(Continued on next page)
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genes were tagged in a pKM461-bearing strain (includingM. smegmatis recG, dnaN, and
ftsK) and were then plated directly on Hyg-sucrose plates both to select for the
recombinant and to cure the strain of the RecT-Int producer. This process appears to
produce moderately fewer colonies than had been observed previously with pKM444
but can more rapidly produce plasmid-free mutants.
Genetic modiﬁcations with ORBIT should be stable. An excision event promoted by
the Bxb1 SSR system requires an additional factor (called gp47 [49]) which is not
present in the hosts used for these experiments. The stability of ORBIT-mediated
FIG 6 Legend (Continued)
smegmatis (b) using ORBIT. In most cases, the oligonucleotides contained an attP site ﬂanked by 70 bases of
target homology. Insertions (C-terminal DAS4 or His-Flag tags) are shown in red, deletions are shown in blue,
and GFP tags are shown in green. Descriptions of all the modiﬁcations performed by ORBIT are provided in
Table 1 (for M. smegmatis) and Table 2 (for M. tuberculosis).
TABLE 1 ORBIT-promoted M. smegmatis modiﬁcations
Gene Designation Function
No. of correct
recombinants/total
no. tested
Flag-Das4 tags
leuB MSMEG_2379 3-Isopropylmalate dehydrogenase 2/4
recA MSMEG_2723 Recombinase 4/4
divIVA MSMEG_4217 DivIVA protein 3/4
dnaN MSMEG_0001 DNA polymerase III, beta subunit 2/2
dinB MSMEG_3172 DNA gyrase 2/2
dnaK MSMEG_0709 Chaperone (heat shock) 1/2
recD MSMEG_1325 ExoV, -subunit 2/4
recB MSMEG_1327 ExoV, -subunit 2/2
adnB MSMEG_1943 ATP-dependent helicase/recombinase 2/2
recG MSMEG_2403 ATP-dependent DNA helicase 2/2
ftsK MSMEG_2690 DNA translocase 3/6
ruvA MSMEG_2944 Holliday junction branch migration 1/2
ruvB MSMEG_2945 Holliday junction branch migration 3/4
ruvC MSMEG_2943 Holliday junction resolvase 1/2
priA MSMEG_3061 Replication restart 2/2
polA MSMEG_3839 DNA polymerase I 4/6
dinB MSMEG_3172 DNA polymerase IV 2/2
fhaB MSMEG_0034 FHA domain-containing protein 6/12
sepF MSMEG_4219 Interaction with FtsZ and MurG 1/2
uvrD2 MSMEG_1952 ATP-dependent DNA helicase 2/2
nucS MSMEG_4493 ssDNA-binding protein 3/4
GFP tags
dnaN MSMEG_0001 DNA polymerase III, beta subunit nra
mmpL3 MSMEG_0205 MmpL family protein nr
sppA MSMEG_1476 Signal peptide peptidase nr
clpC MSMEG_6091 ATP-dependent protease ATP-binding protein nr
MSMEG_3596 ATPase nr
Deletions
ΔrecD MSMEG_1325 ExoV, -subunit 2/4
ΔrecF MSMEG_0003 Replication repair protein 2/4
ΔrecG MSMEG_2403 ATP-dependent DNA helicase 2/2
ΔrecO MSMEG_4491 DNA repair protein 1/2
ΔruvC MSMEG_2943 Holliday junction resolvase 2/6
ΔrecR MSMEG_6279 Recombination protein 4/6
ΔnusS MSMEG_4923 Mismatch repair function nr
MSMEG_4922 Conserved hypothetical protein nr
ΔrhlE MSMEG_1930 RNA helicase nr
ΔdeaD MSMEG_5042 deaD RNA helicase nr
MSMEG_2579 Unknown nr
MSMEG_3027 Unknown nr
MSMEG_4256 NLP/P60 family protein nr
anr, not reported.
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TABLE 2 ORBIT-promoted M. tuberculosis modiﬁcations
Rv no. Gene Function
Knockouts
Rv0244c fadE5 Probable acyl-CoAa dehydrogenase FadE5
Rv0248c Rv0248c Probable succinate dehydrogenase
Rv0249c Rv0249c Probable succinate dehydrogenase
Rv0465c Rv0465c Probable transcriptional regulatory protein
Rv0503c cmaA2 Cyclopropane-fatty-acyl-phospholipid synthase
Rv0645c mmaA1 Methoxy mycolic acid synthase
Rv0928 pstS3 Periplasmic phosphate-binding lipoprotein PstS3
Rv0929 pstC2 Phosphate transport integral membrane ABC transporter
Rv0989c grcC2 Probable polyprenyl-diphosphate synthase
Rv1161–Rv1164 NarG-NarI Nitrate reduction
Rv1174c TB8.4 Low-molecular-weight T-cell antigen TB8.4
Rv1184c Rv1184c Possible exported protein
Rv1253 deaD Probable cold-shock DeaD-box protein A homolog
Rv1273c Rv1273c Probable drug transport transmembrane ABC transporter
Rv1321 nucS Probable mismatch repair protein
Rv1488 Rv1488 Possible exported conserved protein
Rv1543 Rv1543 Possible fatty acyl-CoA reductase
Rv1592 Rv1592 Conserved hypothetical protein
Rv1620c–Rv1623c cyd operon Respiratory chain
Rv1621c cydD Transmembrane ATP-binding protein ABC transporter CydD
Rv1623c cydA Probable integral membrane cytochrome d ubiquinol oxidase
Rv1625c cya adenylate cyclase
Rv1747 Rv1747 Probable conserved transmembrane ABC transporter
Rv1901 cinA Probable CinA-like protein CinA
Rv2047 Rv2047 Conserved hypothetical protein
Rv2048c Pks12 Polyketide synthase
Rv2383c mbtB Phenyloxazoline synthetase
Rv2384 mbtA Salicyl-AMP ligase (SAL-AMP ligase)  salicyl–S-ArCP synthetase
Rv2563 Rv2563 Glutamine transport transmembrane protein ABC transporter
Rv2564 Rv2564 Glutamine transport ATP-binding protein ABC transporter
Rv2684 arsA Probable arsenic transport integral membrane protein ArsA
Rv3136 PPE51 PPE family protein PPE51
Rv3211 rhiE Probable ATP-dependent RNA helicase
Rv3270 ctpC Probable metal cation-transporting P-type ATPase C
Rv3283 sseA Probable thiosulfate sulfurtransferase SseA
Rv3296 lhr Probable ATP-dependent helicase Lhr (large-helicase-related protein)
Rv3544c fadE28 Probable acyl-CoA dehydrogenase
Rv3574 kstR Transcriptional regulatory protein
Rv3680 Rv3680 Probable anion transporter ATPase
Rv3696 glpK Probable glycerol kinase
Rv3822 Rv3822 Conserved hypothetical protein
Rv3869 eccB1 ESX-1 type VII secretion system protein
Insertions (Flag-Das4 tags)
Rv0054 ssb Single-strand-binding protein
Rv0218 Rv0218 Probable conserved transmembrane protein
Rv0228 Rv0228 Probable integral membrane acyltransferase
Rv0556 Rv0556 Probable conserved transmembrane protein
Rv0896 gltA2 Probable citrate synthase
Rv0993 galU UTP–glucose-1-phosphate uridylyltransferase GalU
Rv1005c pabB Probable para-aminobenzoate synthase component
Rv1093 glyA1 Serine hydroxymethyltransferase
Rv1392 metK Probable S-adenosylmethionine synthetase
Rv1475c acn Probable iron-regulated aconitate hydratase
Rv1743 pknE Probable transmembrane serine/threonine protein kinase E
Rv2241 aceE Pyruvate dehydrogenase E1 component
Rv2398c cysW Probable sulfate transport membrane protein ABC transporter
Rv2746c pgsA3 Probable PGP synthase PgsA3
Rv2868c gcpE Probable GcpE protein
Rv2977c thiL Probable thiamine-monophosphate kinase
RV2986c hupB DNA-binding protein HU homolog
Rv3034c Rv3034c Possible transferase
Rv3034c Rv3034c Possible transferase
Rv3206c moeB1 Probable molybdenum cofactor biosynthesis protein MoeB1
Rv3212 Conserved alanine-valine-rich protein
(Continued on next page)
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modiﬁcations was veriﬁed by observing that the pKM468 integrated payload plasmid,
after integration into theM. smegmatisMSMEG_3596 and MSMEG_0250 genes, was not
lost after more than 100 generations of growth in the absence of drug selection, as
shown by detection of equal numbers of colonies on LB plates with and without ATc.
In addition, both PCR analysis and ﬂuorescence microscopy were employed to verify
the continued presence of the green ﬂuorescent protein (GFP) tag in both strains.
All the ORBIT-promoted gene modiﬁcations described in Tables 1 and 2 were done
with M. smegmatis or M. tuberculosis already transformed with either pKM444 or
pKM461. In order to investigate the possibility that transient expression of RecT and
Bxb1 integrase would be sufﬁcient to promote recombinant formation by ORBIT, we
deleted the oriM sequence from pKM444 and electroporated the resulting plasmid with
pKM446 and an ORBIT oligonucleotide designed to fuse the Flag-DAS4 tag to the
C-terminal end of dnaN. In standard ORBIT experiments, this target typically gave the
highest number of colonies relative to other M. smegmatis genes, possibly as a result
of its close proximity to the chromosomal origin of replication. However, in experiments
performed using the pKM444 derivative missing oriM, the numbers of colonies ob-
served were no greater than the numbers of colonies observed with cells that were
transformed with the plasmids but not with the oligonucleotide. Furthermore, results
of PCR analyses of eight candidates from this experiment were negative for the
presence of the 5= junction of the expected recombinant. It seems likely that RecT is
required to be present in abundance prior to entry of the oligonucleotide into the cell
to protect the oligonucleotide from digestion by cellular nucleases and/or to efﬁciently
deliver the oligonucleotide to the replication fork.
Expanding the library of ORBIT-mediated modiﬁcations. In order to expand the
types of modiﬁcations that can be made via ORBIT, we built a set of payload plasmids
containing the Bxb1 attB site fused to different types of tags. In addition to the
Flag-DAS4 plasmids, we generated plasmids to create C-terminal targeted fusions
with combinations of enhanced GFP (eGFP), mVenus, SNAP, CLIP, Myc and His epitopes
and tobacco etch virus (TEV) cleavage sites. These tags facilitate both protein localiza-
tion studies performed by ﬂuorescence analysis and afﬁnity puriﬁcations (Table 3). In
addition, we created plasmids to generate chromosomal knockouts and promoter
replacements using either hygromycin resistance or zeocin resistance (Zeor) as a
method of selection for the recombinant (see Table 3). Any number of payload
plasmids can be matched with a single targeting oligonucleotide to generate a variety
of functional gene modiﬁcations.
As with any chromosomal engineering method, one must consider the effect of the
modiﬁcation on expression of downstream functions, especially if the target gene is
within an operon. The pKM464 ORBIT knockout plasmid was designed such that once
integrated, the hyg gene is positioned at the junction of the insertion site, allowing
downstream genes to be transcribed by the hyg promoter. In our experience, this is
generally sufﬁcient for the generation of most mutations (see Table 1 for knockouts
generated in M. smegmatis). For additional options, pKM495 (for Flag-DAS4 tags) and
pKM496 (for knockouts) contain an additional promoter (PGroEL) to drive higher tran-
scription levels downstream of the insertion site (Table 3). Similar plasmids can be
generated with promoters of various strengths, as needed.
TABLE 2 (Continued)
Rv no. Gene Function
Rv3370c dnaE2 DNA polymerase III (alpha chain)
Rv3410c guaB3 Probable inosine-5=-monophosphate dehydrogenase
Rv3441c mrsA Probable phospho-sugar mutase
Rv3465 rmlC dTDP-4-dehydrorhamnose 3,5-epimerase
Rv3484 cpsA Possible conserved protein CpsA
Rv3581c ispF Probable 2C-methyl-D-erythritol 2,4-cyclodiphosphate synthase
Rv3663c dppD Probable dipeptide transport ATP-binding protein
Rv3910 Rv3910 Probable conserved transmembrane protein
aCoA, coenzyme A.
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GFP fusions. To demonstrate the functionality of these additional tags, ORBIT was
used to construct eGFP fusions with a number ofM. smegmatis genes. We tagged DnaN
(the beta subunit of DNA polymerase III) and MmpL3 (the essential mycolate trans-
porter suspected to reside at the pole), two proteins known to be located in discrete
cytoplasmic foci, and three genes with unknown distribution patterns. The pKM468
eGFP payload plasmid (Table 3) was used to tag each gene in situ at the endogenous
chromosomal locus. MmpL3-eGFP and DnaN-eGFP were concentrated at the predicted
localization site of each protein (Fig. 7). For DnaN-GFP, the punctate spots identify
positions of the replication forks that occurred in nonpolar regions of the cell (see Fig. 7),
in accordance with previous observations (58). eGFP-tagged alleles of MSMEG_
3596, SppA, and ClpC were found at distinct sites, a result which differed from the
diffuse cytosolic distribution of unfused eGFP. Overall, ORBIT is a rapid and efﬁcient
method to modify native genes in the chromosome with functionally distinct tags
without having to create target- and modiﬁcation-speciﬁc dsDNA recombination sub-
strates. Also, by expressing each gene at its native level, aberrant localization or
complex formation due to overexpression can be avoided.
Promoter replacements. One can also integrate attB-containing ORBIT plasmids to
change the endogenous levels of expression of a chromosomal gene. We constructed
a series of ORBIT plasmids containing promoters of different strengths that can be used
to drive the expression of genes downstream of the plasmid insertion site (see the
promoter replacement plasmids listed in Table 3). To use these plasmids, the ORBIT
oligonucleotide is designed to replace the endogenous promoter with attP. The target
gene’s ribosome-binding site, if recognized, can also be deleted, replaced, or left intact,
depending on the ﬁnal level of expression desired. To test this scheme, we performed
ORBIT in an M. smegmatis strain where a chromosomal lacZ gene is under the control
of the mycobacterial PAg85 promoter containing a weak ribosome-binding site.
ORBIT was used to replace PAg85 with one of three different promoters: Pimyc,
PGroEL, or P38. Plasmids containing these promoters are listed according to increasing
strength of expression (D. Schnappinger, personal communication). The promoters
were transferred to ORBIT integration plasmids and placed upstream of the Bxb1 attB
site (see Fig. 8a). An optimized ribosome-binding site (rbs: AGAAAGGAGGAAGGA) was
included between the promoters and the attB site to increase the overall level of
TABLE 3 ORBIT integration plasmidsa
Plasmid name Type of modiﬁcation
Drug resistance
marker Addgene ID
C-terminal tags
pKM446 C-terminal tag: Flag-DAS tag Hygr 108321
pKM468 C-terminal tag: EGFP-4Gly-TEV–Flag-6His Hygr 108434
pKM469 C-terminal tag: Venus-4Gly-TEV–Flag-6His Hygr 108435
pKM489 C terminal tag: SNAP tag Hygr 108437
pKM490 C-terminal tag: CLIP tag Hygr 109281
pKM491 C-terminal tag: 4Gly-TEV–Flag-6His Hygr 109282
pKM492 C-terminal tag: 4Gly-TEV-Myc-6His Hygr 109283
pKM493 C-terminal tag: TEV–Flag-4Gly-EGFP Hygr In process
pKM495 C-terminal tag: Flag-DAS tag Zeor 109284
Knockouts
pKM464 Knockout Hygr 108322
pKM496 Knockout Zeor 109301
Promoter replacements
pKM464 Replacement of endogenous promoter with PHyg Hygr 108322
pKM496 Replacement of endogenous promoter with PGroEL (op-rbs)b Zeor 109301
pKM508 Replacement of endogenous promoter with P21 (op-rbs) Zeor In process
pKM509 Replacement of endogenous promoter with P38 (op-rbs) Zeor In process
aAll plasmids contain the chloramphenicol resistant cassette (Camr) for use during isolation of the plasmid grown in E. coli. ID, identiﬁer; In process, to be added at a
later date.
bOptimized ribosome binding site (AGAAAGGAGGAAGGA).
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expression of -galactosidase relative to the starting strain, where an endogenous
Shine-Delgarno sequence could not be recognized. In this arrangement, the ﬁnal
recombinant had an attR site situated between the promoter-SD sequence and the
translational start site of the target gene (see Fig. 8a). (Alternatively, an altered SD
sequence can be included in the oligonucleotide sequence, thereby placing it closer to
the start codon of the target gene.) ORBIT recombinants were identiﬁed by resistance
to zeocin and veriﬁed by chromosomal PCR analysis as described above. The total
amount of -galactosidase in each extract increased in accordance with the expected
strengths of the three promoters used in these assays (Fig. 8b). Thus, endogenous
promoters can be easily replaced to modify the expression level of a chromosomally
located target gene.
Markerless gene deletions. The ORBIT protocol represents a unique way to con-
struct markerless gene deletions in a process involving reversal of plasmid integration
step. The Bxb1 phage produces the gp47 protein, which has been shown to be a
recombination directionality factor (RDF) (49). Along with the Bxb1 integrase, gp47 acts
to promote site-speciﬁc recombination between attL and attR, restoring the attP site. By
replacing recT with gp47 in pKM461 and exchanging the Hygr gene with a Zeor cassette
(ble), a plasmid was generated that expresses both gp47 and integrase under the
control of Ptet (pKM512). The M. smegmatis ORBIT-generated deletion strain
ΔMSMEG_4392, not yet cured of the Kanr plasmid pKM461, was transformed with
pKM512 (Zeor), grown in the presence of anhydrotetracycline (ATc), and plated on
7H10-sucrose plates as described in Materials and Methods. Of 37 colonies of strain
ΔMSMEG_4392 treated in this manner, 7 were sensitive to hygromycin; in addition, all
of them were sensitive to both kanamycin and zeocin. Site-speciﬁc recombination
between the attR and attL sites replaces the deleted portion of MSMEG_4392 with the
attP site, creating an in-frame deletion, which was veriﬁed by sequencing in 4 of the 7
HygS colonies described above. Thus, mutants of mycobacteria devoid of any antibiotic
resistance can be generated following construction of ORBIT-generated deletions.
FIG 7 ORBIT-generated GFP fusions. M. smegmatis cells containing GFP-tagged target genes were grown in 7H9-AD-Tween 80 to an optical density of 0.8. One
microliter of the culture was spotted on an agarose pad for microscopy. Each bacterial strain was imaged using differential interference contrast (DIC) and GFP
channels, as described in Material and Methods.
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DISCUSSION
The  Red recombineering system has been critical for genome engineering of E. coli
and related bacteria. While  Red does not function well in bacteria more distantly
related to E. coli, endogenous phage recombination systems have been identiﬁed and
employed to promote recombineering in these organisms. One of the more notable
examples of a phage recombination system utilized in this way is the Che9c mycobac-
terial RecET system, identiﬁed by Van Kessel and Hatfull and used for recombineering
of the M. smegmatis and M. tuberculosis chromosomes (18, 19, 22). This recombineering
system has been used to construct numerous knockouts and modiﬁcations of myco-
bacterial targets (22, 32, 59, 60). However, unlike  Red recombineering in E. coli, PCR
substrates of 50-bp ﬂanking homology do not work efﬁciently for recombineering in M.
smegmatis and M. tuberculosis, though longer homologies can be added by PCRs
performed with long oligonucleotides containing 50 to 100 bp of additional target
homologies (61). To increase recombination efﬁciency further, one needs to construct
recombineering substrates containing 500 bp of ﬂanking homology for each speciﬁc
modiﬁcation. Similarly, specialized transduction also requires the laborious construction
and packaging of a different recombination substrate-containing phagemid for each
genome modiﬁcation (62).
ORBIT overcomes the limitations of existing methods by combining components of
two different efﬁcient recombination systems from mycobacteria: the Che9c annealase
from the general homologous recombination system and the Bxb1 integrase from the
site-speciﬁc recombination system. The construction of long dsDNA recombination
substrates is replaced by the synthesis of a targeting oligonucleotide, and the avail-
ability of a library of payload plasmids allows a single oligonucleotide to be used to
FIG 8 Promoter replacements. (a) Diagram of ORBIT-generated promoter replacements. In the nonrepli-
cating plasmid, the promoter to be inserted into the chromosome is placed to the left of the attB site. A
TrrnB terminator is placed upstream of this promoter to prevent read-through from the plasmid backbone.
The oligonucleotide is designed to place attP just upstream of the target gene in place of the endogenous
promoter. Following integration, the promoter and inserted ribosome-binding site drive expression of the
chromosomal target gene (lacZ). (b) ORBIT was carried out with plasmids pKM496 (PGroEL), pKM508 (Pimyc),
and pKM509 (P38) with an oligonucleotide that deletes the endogenous promoter. Extracts of the cells
were made, and beta-galactosidase assays were performed in triplicate (standard error bars are shown). The
higher amounts of beta-galactosidase present in the engineered strains, relative to the starting strain, were
likely due to the presence of the optimized ribosome-binding site following each promoter.
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generate a wide variety of functional modiﬁcations. The ability to direct the insertion of
functionally distinct payloads creates a precise and versatile “drag and drop” strategy
for genome engineering.
The utility of ORBIT extends beyond the simple generation of mutants. Since
targeting oligonucleotides are easily generated, the system is well suited for the
construction of libraries of mutants. The targeting oligonucleotide loop containing the
48-bp attP site can be extended to 60 bp (Fig. 1) to include a nearly inﬁnite number of
unique DNA barcode sequences, which would allow each mutant in a large ORBIT-
generated pool to be monitored independently by PCR or next-generation sequencing.
The variety of modiﬁcations that can be made with the existing collection of payload
plasmids opens new avenues for functional screening of mutant libraries that are
generated using this method. ORBIT can also be used for genome reduction strategies
in M. tuberculosis. The largest deletion generated in this study was the one-step 12-kb
deletion of the pks12 gene, and it is likely that larger deletions are possible. Finally,
though most of the payload plasmids described in this report were designed to modify
endogenous genes, one could also use this strategy to place exogenous elements, such
as large clusters of biosynthetic genes, into any speciﬁed position in the mycobacterial
chromosome.
The paradigm of ORBIT is likely to be useful in many different bacterial species. The
Bxb1 integrase requires no host functions to carry out the site-speciﬁc and directional
(attB  attP) recombination reaction. It is for these reasons that Bxb1 integrase has
been selectively employed for genetic manipulations in both bacterial and mammalian
cells (63, 64). Thus, the key to the development of ORBIT for other microbial systems
would be to ﬁnd a  Beta or RecT-like annealase that promotes some level of
oligonucleotide-mediated recombineering. Datta et al. (65) have tested a number of
single-stranded annealing proteins (SSAPs) from both Gram-positive and Gram-
negative bacteria for oligonucleotide-mediated recombineering in E. coli. While the
recombineering efﬁciency ranged over 3 orders of magnitude, some SSAPs from distant
species worked as well as the  Beta protein in E. coli, suggesting that some annealases
are easily transferable between species. An annealase appropriate for use in ORBIT
would have to be able to promote annealing of an oligonucleotide containing a 48-bp
attP insertion. Note, however, that even if oligonucleotide recombineering were to
occur at low frequencies (106) with such a substrate, the number of attP sites
generated could very well be adequate for the Bxb1 integrase to promote integration
of a nonreplicating plasmid, thus making integration of the oligonucleotide a selectable
event.
MATERIALS AND METHODS
Bacterial strains. The M. smegmatis strains used in this study were derived from mc2155; the M.
tuberculosis strains were all derived from H37Rv.
Media.M. smegmatis was grown in Middlebrook 7H9 broth with 0.05% Tween 80, 0.2% glycerol, 0.5%
bovine serum albumin (BSA), 0.2% dextrose, and 0.085% NaCl; transformants were selected on LB plates
(Difco) with appropriate drugs. M. tuberculosis was grown in 7H9 broth with 0.05% Tween 80, 0.2%
glycerol, and OADC (oleic acid-albumin-dextrose-catalase; Becton, Dickinson); transformants were se-
lected on 7H10 plates with 0.5% glycerol and OADC. When needed, the following antibiotics (concen-
trations) were added: kanamycin (20 g/ml), streptomycin (20 g/ml), hygromycin (50 g/ml), and
zeocin (25 g/ml).
Plasmids. Plasmids containing the Pimyc promoter (66), the PGroEL promoter, and P38 promoter were
obtained from D. Schnappinger and S. Ehrt, as were plasmids pGMCgS-TetOFF-18 and pGMCgS-TetON-
18, where the E. coli SspB adapter protein is under the control of the wild-type and reverse TetR
repressors, respectively. Plasmids constructed for this study are described in Tables 3 and 4 and are
TABLE 4 ORBIT-testing and RecT-Int-expressing plasmids
Plasmid Functions Drug resistance Addgene ID
pKM433 Phage L5 integrating vector; HygΔ60-bp internal deletion; oriE Zeor
pKM444 PTet-Che9c RecT-Bxb1 Int; TetR, oriE, oriM Kanr 108319
pKM461 PTet-Che9c RecT-Bxb1 Int; SacRB; TetR, oriE, oriM Kanr 108320
pKM512 PTet-Bxb1 GP47-Int; SacRB; TetR, oriE, oriM Zeor In process
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available at the Addgene plasmid repository site. Details of plasmid constructions are available upon
request.
Oligonucleotides. Oligonucleotides used for ORBIT were obtained from IDT as Ultramers at a
concentration of 100 uM and delivered in 96-well plates; they were supplied desalted with no further
puriﬁcation. Oligonucleotides were diluted 10-fold in 10 mM Tris-HCl (pH 8.0), and ﬁnal concentrations
(250 to 350 ng/ml) were determined by analysis of absorbance maxima at 260 nm (Abs260) using a
conversion factor of an optical density (OD) of 1 20 g/ml oligonucleotide. ORBIT plasmids (200 ng)
were mixed with 1 g of oligonucleotide prior to electroporation, unless stated otherwise in ﬁgure
legends.
Design of the ORBIT oligonucleotide. The sequence of oligonucleotides ﬂanking the attP site used
for ORBIT must be derived from the lagging strand of the replication fork. For design of an ORBIT
oligonucleotide, a dsDNA sequence ﬁle of a target gene was created, starting 200 bp upstream of the
initiation codon and ending 200 bp downstream of the stop codon. The Bxb1 attP site (shown in Fig. S4
in the supplemental material) was inserted into the target sequence ﬁle for the type of modiﬁcation
required (i.e., knockout, C-terminal tag, or promoter replacement) as described in Results. For selection
of the lagging strand, the rules are as follows: if the transcriptional direction of the target gene is pointing
toward the chromosomal origin in either replicore (green arrows in Fig. S4), then select the top strand
(5= to 3=) of the “target sequence  attP” ﬁle as the lagging strand DNA in the oligonucleotide. If the
transcriptional direction of the target gene is pointing away from the chromosomal origin in either
replicore (red arrows in Fig. S4), then select the bottom strand (5= to 3=) of the “target sequence  attP”
ﬁle as the lagging strand in the oligonucleotide. The example shown in Fig. S4 is for M. smegmatis. Apply
the same rules for M. tuberculosis, but assume that the dif region occurs at 2.2 Mb. For further details, see
reference 22.
ORBIT electroporations. A culture of M. smegmatis containing plasmid pKM444 (or pKM461) was
started overnight by adding 100 to 150 l of a fresh saturated stock culture to 20 ml of 7H9 media
containing 20 g/ml kanamycin in a 125-ml ﬂask. Cells were grown on a swirling platform at 37°C. The
next day, at an OD (600 nm) of 0.5, anhydrotetracycline (ATc) was added to reach a ﬁnal concentration
of 500 ng/ml. The culture was placed back on the swirling platform at 37°C for 2.5 to 3 h until the culture
OD was 1.0. The culture was then placed on ice (with swirling) for 10 min and centrifuged in 50-ml
conical tubes at 4,000 rpm for 10 min in a chilled centrifuge. The supernatant was removed, and the
pellet was gently resuspended in 2 ml of 10% cold glycerol and then brought up to 20 ml with 10% cold
glycerol. The tube was inverted a few times to promote mixing. The centrifugation and washing steps
were repeated. After the second wash, the cells were collected by centrifugation and resuspended in 2 ml
of 10% cold glycerol. Aliquots (380 l) of electrocompetent cells were added to sterile Eppendorf tubes
containing 1 g of an attP-containing oligonucleotide and 200 ng of an attB-containing plasmid (except
where noted otherwise in ﬁgure legends). The cells and DNA were mixed by pipetting and transferred
to ice-cooled electroporation cuvettes (0.2 cm path length). The cells were shocked with an electropo-
rator at settings of 2.5 kV, 1,000 , and 25 F. Following electroporation, the cells were resuspended in
2 ml 7H9 media and rolled at 37°C overnight. The following day, two 0.5-ml portions of the culture were
spread on LB plates containing 50 g/ml hygromycin (or 25 g/ml zeocin). Plates were incubated for 4
to 5 days at 37°C, and recombinant candidate colonies were picked and suspended in 2 ml 7H9 media
containing 50 g/ml hygromycin (or 25 g/ml zeocin) and grown overnight at 37°C. Control electropo-
rations with plasmid but without oligonucleotides were also performed.
Electroporations with M. tuberculosis were performed in a similar manner, with the following
modiﬁcations. Cells containing pKM444 (or pKM461) were grown in 30 ml 7H9 media containing OADC,
0.2% glycerol, 0.05% Tween 80, and 20 g/ml kanamycin. At an OD of0.8, ATc was added to the culture
to reach a ﬁnal concentration of 500 ng/ml. After 8 h of swirling at 37°C, 3 ml of 2 M glycine was added
to the culture. The cells were shaken at 37°C overnight (16 h to 20 h in total following induction),
collected by centrifugation, and processed as described above, except that all steps were performed at
room temperature. Recombinant candidate colonies were picked after 3 weeks into 5 ml 7H9-OADC-
Tween containing 50 g/ml hygromycin and grown with shaking for 4 to 5 days at 37°C.
PCR analysis for veriﬁcation of recombinants. Recombinants were veriﬁed by PCR analysis; Taq
polymerase was obtained from Denville Scientiﬁc, Inc. PCRs were performed with 30-l volumes and
contained 125 M deoxynucleoside triphosphates (dNTPs), 5% dimethyl sulfoxide (DSMO), 1 M primers,
2 l of an M. smegmatis overnight culture (or of a heat-inactivated M. tuberculosis culture), and 0.2 l of
Taq polymerase. M. tuberculosis cells (OD around 1.5) were heat inactivated at 85°C for 50 min prior to
removal from the biosafety level 3 (BSL3) laboratory. The PCR program consisted of an initial step of 95°C
for 5 min (to lyse the cells); 30 cycles of 30 s at 95°C, 30 s at 58°C, and 1 min at 72°C; and a ﬁnal
polymerization step of 5 min at 72°C. Correctly sized PCR fragments were generated from both junctions
of the payload plasmid inserted into the chromosome (see Fig. 2e). In each case, the 5= junction was
veriﬁed by the use of a target-speciﬁc primer and an “oriE” primer (CCTGGTATCTTTATAGTCCTGTCG); the
3= junction was veriﬁed by the use of a target-speciﬁc primer and a “HygC-out” primer (TGCACGGGAC
CAACACCTTCGTGG or GAGGAACTGGCGCAGTTCCTCTGG). In some cases, the 5= junction PCR was veriﬁed
by sequencing. Target-speciﬁc primers contained sequences at least 100 bp upstream (5=) and down-
stream (3=) of the chromosomal sequences ﬂanking the attP site in the ORBIT oligonucleotide. For
knockouts, an additional PCR was performed to verify the absence of the target gene in the recombinant.
Spot titer assays. Following ORBIT-promoted C-terminal tagging of M. smegmatis recA, divIVA, and
leuB genes, cells were transformed with either pGMCgS-TetOFF-18 or pGMCgS-TetON-18 (SspB-
producing plasmids) by selection for streptomycin resistance (20 g/ml); ORBIT plasmid pKM444 (Kanr)
was not cured beforehand. Cells were grown overnight in 7H9-AD-Tween broth containing 20 g/ml
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streptomycin. Ten-fold serial dilutions of the cultures were made in phosphate-bufferd saline (PBS)-
Tween, and 10-l volumes of the dilutions were spotted on LB or 7H10-AD-Tween plates containing
20 g/ml streptomycin, either with or without 500 ng/ml anhydrotetracycline. Plates were wrapped in
aluminum foil and incubated for 3 to 4 days at 37°C. For the recA strains, plates were exposed to UV prior
to incubation. See the Fig. 3 legend for additional details.
Fluorescence microscopy. Bacterial cells were mounted on 1% agar pads and imaged with a
DeltaVision Personal DV microscope followed by deconvolution using SoftwoRx software (Applied
Precision). Further processing was performed using FIJI software (67). Image brightness and contrast
were adjusted for visibility, and the ﬁles were converted to 600 dots per inch (dpi). Representative cells
are shown from multiple images of each strain.
Beta-galactosidase activity assay. A 5-ml volume of culture at an OD of 0.8 to 1.0 was pelleted and
resuspended in 1 ml of freshly prepared Z buffer (50 mM Na2HPO4 [pH 7.0], 10 mM KCl, 1 mM MgSO4,
50 mM -mercaptoethanol). Cells were lysed by bead beating 4 times at 6.5 m/s for 30 s followed by
centrifugation for 10 min to harvest the supernatant. Protein concentrations were measured with a
NanoDrop instrument. For the activity assay, 10-g volumes of protein and Z buffer (total volume of
100 l) were added in triplicate to a 96-well microplate. The reaction was started with 20 l of 4 mg/ml
o-nitrophenyl--D-galactopyranoside (ONPG) mixed with sodium phosphate buffer (0.1 M; pH 7.0). Once
sufﬁcient yellow color had developed, the reaction was terminated with 50 l of 1 M sodium carbonate.
Final absorbance of the sample was measured at 420 nm in a plate reader.
Markerless gene deletions. The M. smegmatis ORBIT-generated deletion strain ΔSMEG_4392 har-
boring the pKM464 plasmid (Hygr) was transformed with pKM512 (Zeor), a plasmid expressing the Bxb1
excisionase functions (gp47 and Int) and SacRB. The selection for zeocin resistance allows curing of
pKM461 (Kanr) by plasmid incompatibility. After overnight growth of the Zeor transformant in 7H10
containing 500 ng/ml anhydrotetracycline, cells were plated on 7H10 plates containing 10% sucrose.
Single colonies from these plates were streaked on 7H10, 7H10-Hyg, and 7H10-Zeo plates. Colonies
found sensitive to hygromycin were also sensitive to both kanamycin and zeocin.
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